急诊科留观期间的治疗与临床病程对重症患者严重度评分及预测死亡风险的影响
该多中心观察性队列研究链接荷兰NEED与NICE两个质量登记库,纳入1398例从急诊收入ICU的患者,比较基于ICU入科后首个24小时数据的APACHE-IV与基于急诊最异常生理变量的ED APACHE-IV模型。ICU APACHE-IV预测死亡风险中位数0.10(IQR 0.03-0.30),显著低于ED APACHE-IV模型的0.13(IQR 0.04-0.36,p<0.01);SMR由0.63(95%CI 0.54-0.72)变为0.55(95%CI 0.47-0.63)。321例(23.2%)患者预测死亡风险变化超过5%。急诊停留时间>3.9小时者较<1.7小时者delta APACHE-IV轻度增加1.6(95%CI 0.4-2.8)。作者认为,若各医院在急诊稳定患者的策略不同,基于APACHE-IV的预测死亡风险与SMR不能直接比较。
要点
- 从急诊收入ICU的患者,基于急诊最异常生理变量的ED APACHE-IV预测死亡风险中位数0.13(IQR 0.04-0.36),高于ICU APACHE-IV的0.10(IQR 0.03-0.30),p<0.01。
- 改用ED APACHE-IV后SMR由0.63(95%CI 0.54-0.72)降至0.55(95%CI 0.47-0.63)。
- 321例(23.2%)患者因改用ED APACHE-IV预测死亡风险变化超过5%。
- 急诊停留时间>3.9小时者较<1.7小时者delta APACHE-IV增加1.6(95%CI 0.4-2.8)。
- 作者认为,若医院间急诊稳定策略不同,APACHE-IV预测死亡风险与SMR不能直接比较。
适用人群与场景
- 从急诊收入ICU的患者,数据来自荷兰NEED与NICE两个质量登记库。
研究设计与关键结果
- 多中心观察性队列研究,共纳入1398例从急诊收入ICU的患者。
- ICU APACHE-IV预测死亡风险中位数0.10(IQR 0.03-0.30),ED APACHE-IV模型为0.13(IQR 0.04-0.36),前者显著低于后者(p<0.01)。
- SMR由基于ICU APACHE-IV的0.63(95%CI 0.54-0.72)变为基于ED APACHE-IV的0.55(95%CI 0.47-0.63)。
- 321例(23.2%)患者因改用ED APACHE-IV预测死亡风险变化超过5%。
- 急诊停留时间>3.9小时者较<1.7小时者delta APACHE-IV增加1.6(95%CI 0.4-2.8)。
证据类型、等级与局限
- 证据类型:多中心观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,若各医院在急诊稳定患者的策略不同,基于APACHE-IV的预测死亡风险与SMR不能直接比较。
- 作者提出,未来研究应聚焦于开发校正这些差异的模型。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Treatment and the clinical course during Emergency Department (ED) stay before Intensive Care Unit (ICU) admission may affect predicted mortality risk calculated by the Acute Physiology and Chronic Health Evaluation (APACHE)-IV, causing lead-time bias. As a result, comparing standardized mortality ratios (SMRs) among hospitals may be difficult if they differ in the location where initial stabilization takes place. The aim of this study was to assess to what extent predicted mortality risk would be affected if the APACHE-IV score was recalculated with the initial physiological variables from the ED. Secondly, to evaluate whether ED Length of Stay (LOS) was associated with a change (delta) in these APACHE-IV scores.
METHODS: An observational multicenter cohort study including ICU patients admitted from the ED. Data from two Dutch quality registries were linked: the Netherlands Emergency department Evaluation Database (NEED) and the National Intensive Care Evaluation (NICE) registry. The ICU APACHE-IV, predicted mortality, and SMR based on data of the first 24 h of ICU admission were compared with an ED APACHE-IV model, using the most deviating physiological variables from the ED or ICU.
RESULTS: A total of 1398 patients were included. The predicted mortality from the ICU APACHE-IV (median 0.10; IQR 0.03-0.30) was significantly lower compared to the ED APACHE-IV model (median 0.13; 0.04-0.36; p < 0.01). The SMR changed from 0.63 (95%CI 0.54-0.72) to 0.55 (95%CI 0.47-0.63) based on ED APACHE-IV. Predicted mortality risk changed more than 5% in 321 (23.2%) patients by using the ED APACHE-IV. ED LOS > 3.9 h was associated with a slight increase in delta APACHE-IV of 1.6 (95% CI 0.4-2.8) compared to ED LOS < 1.7 h.
CONCLUSION: Predicted mortality risks and SMRs calculated by the APACHE IV scores are not directly comparable in patients admitted from the ED if hospitals differ in their policy to stabilize patients in the ED before ICU admission. Future research should focus on developing models to adjust for these differences.
参考来源
- Candel BGJ, Raven W, Lameijer H, et al. The effect of treatment and clinical course during Emergency Department stay on severity scoring and predicted mortality risk in Intensive Care patients. Crit Care. 2022. PMID: 35440007. doi:10.1186/s13054-022-03986-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。